Peroxisome-Proliferator-Activated Receptors (PPARs) Are Potential Drug Targets for Cancer Therapy

Oncotarget - United States
doi 10.18632/oncotarget.19610
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Peroxisome Proliferator-Activated Receptors (Ppars) in Health and Disease.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2002English

Peroxisome Proliferator-Activated Receptors: Targets for the Treatment of Metabolic Illnesses (Review)

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2008English

S⋅⋅⋅Sn Tetrel Bonds in the Activation of Peroxisome Proliferator-Activated Receptors (PPARs) by Organotin Molecules

Chemistry - A European Journal
Organic ChemistryCatalysisChemistry
2018English

Drugs and the Peroxisome Proliferator Activated Receptors

2014English

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus

Therapeutic Advances in Gastroenterology
Gastroenterology
2011English

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection

PPAR Research
Drug DiscoveryPharmacology
2009English

Nuclear Receptors as Targets for Drug Development: Peroxisome Proliferator-Activated Receptor Γ in Mast Cells: Its Roles in Proliferation and Differentiation

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2005English

Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γLigands in Lung Cancer

PPAR Research
Drug DiscoveryPharmacology
2008English

The Effects of Gemfibrozil and Ovariectomy on the Peroxisome Proliferator Activated Receptors (PPARs) in Mice With Experimentally Induced Obesity

Kafkas Universitesi Veteriner Fakultesi Dergisi
Veterinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy